Addressing the Biggest Challenges in Polymorphism
In this episode, a roundtable of distinguished guests discuss the impact and challenges of polymorphism. You’ll hear from these life science and pharmaceutical experts:
- Eyal Barash, Life Sciences Patent Attorney and Founder at Barash Law
- Steve Byrn, Professor and Dept. Head at Purdue University
- Mansoor Khan, Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University
- Ken Morris, University Professor, Director Lachman Institute for Pharmaceutical Analysis, Long Island University
- Ann Newman, Solid-State and Pharmaceutical Consultant at Seventh Street Development Group
- Raj Suryanarayanan, Professor and WIlliam and Mildred Peters Endowed Chair at University of Minnesota
We talked about:
- The guests’ backgrounds and origin stories in life science
- The biggest challenges with respect to polymorphism
- Thinking in terms of practical benefit vs. the clinical benefit
- Distinguishing the formulation effect from the form effect
This episode is Part 1 of 2 on our polymorph roundtable discussion. Don’t miss the conclusion!
For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.
Listening on a desktop & can’t see the links? Just search for The Pharma Lab Show in your favorite podcast player.
- Eyal Barash, Life Sciences Patent Attorney and Founder at Barash Law
- Steve Byrn, Professor and Dept. Head at Purdue University
- Mansoor Khan, Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University
- Ken Morris, University Professor, Director Lachman Institute for Pharmaceutical Analysis, Long Island University
- Ann Newman, Solid-State and Pharmaceutical Consultant at Seventh Street Development Group
- Raj Suryanarayanan, Professor and WIlliam and Mildred Peters Endowed Chair at University of Minnesota
We talked about:
- The guests’ backgrounds and origin stories in life science
- The biggest challenges with respect to polymorphism
- Thinking in terms of practical benefit vs. the clinical benefit
- Distinguishing the formulation effect from the form effect
This episode is Part 1 of 2 on our polymorph roundtable discussion. Don’t miss the conclusion!
For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.
Listening on a desktop & can’t see the links? Just search for The Pharma Lab Show in your favorite podcast player.
The podcast The Pharma Lab Show is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.